ArticleInvestigational new drugs2022

ERK inhibitor ASN007 effectively overcomes acquired resistance to EGFR inhibitor in non-small cell lung cancer.

Bo Mi Ku et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.